glp 1 and bupropion GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 Medications and Their Role

There is limited research on the head-to-head comparison of cardioprotective effects of GLP-1RAs and SGLT2 inhibitors, and the reason(s) for the similarity in the cardioprotective effect of these drug classes is not fully understood

It would take a leap of faith for a drug company to think there was something actually in this, Raufman said

Understanding the why behind a biological response is what separates speculation from science

Some state boards adopted near-verbatim language, proposing burdensome documentation requirements or strict adherence to branded drug dosageseven when prescribed differently by licensed physicians

Stroke J Cerebral Circ